Despite the oncogenic role played by METTL13’s enhanced expression in many types of tumors, this molecule is underexpressed in ccRCC and its low expression is associated with poor prognosis according to public datasets, which aroused our interest in further research. The gene discussed is METTL13; the disease is nonpapillary renal cell carcinoma.